National Cancer Institute
Found 536 results for your search:
Total relevant funding to Ovarian Cancer for this search:
$100,558,561
Fiscal Year FY 2013
Cancer Type [Ovarian Cancer]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 536 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQD3) The role and therapeutic potential of ZNF304 in Ovarian Cancer 1R21CA180145-01 $208,800 $208,800 Ozpolat, Bulent UT MD ANDERSON CANCER CTR
2
1) Computing Services for DCP; 2) Prostate, Lung, Colorectal, and Ovarian (PLCO) N01CA130008 $4,401,871 $1,100,468 UNKNOWN, UNKNOWN INFORMATION MANAGEMENT SERVICES, INC.
3
A Novel Approach for the Routine Screening for Ovarian Cancer 5R01CA164940-02 $399,736 $399,736 PANNELL, LEWIS UNIVERSITY OF SOUTH ALABAMA
4
A Novel IgE Cancer Therapeutic Specific for the Epithelial Membrane Protein-2 1R21CA179680-01 $167,475 $55,267 Daniels-Wells, Tracy UNIVERSITY OF CALIFORNIA LOS ANGELES
5
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC 5R44CA139841-03 $619,304 $154,826 PRABHAKARPANDIAN, BALABHASKAR CFD RESEARCH CORPORATION
6
A novel role for PARP1 in regulation of autophagy 1R21CA178111-01 $165,300 $165,300 WU, GEN WAYNE STATE UNIVERSITY
7
A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer 1K99CA166228-01A1 $99,860 $99,860 Gatza, Michael UNIV OF NORTH CAROLINA CHAPEL HILL
8
A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc 5R01CA134424-05 $366,555 $366,555 KOSTUK, RAYMOND UNIVERSITY OF ARIZONA
9
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer 5R01CA168900-02 $312,080 $156,040 Powell, Daniel UNIVERSITY OF PENNSYLVANIA
10
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,117,473 $55,874 Sinha, Rashmi DCEG (NCI)
11
Abramson Cancer Center Support Grant 3P30CA016520-37S2 $12,499 $500 DANG, CHI UNIVERSITY OF PENNSYLVANIA
12
Abramson Cancer Center Support Grant 5P30CA016520-37 $7,216,850 $288,674 DANG, CHI UNIVERSITY OF PENNSYLVANIA
13
Activatable molecular cancer imaging probe ZIA BC 011512 $103,603 $10,360 Kobayashi, Hisataka CCR (NCI)
14
Adaptations and methodologies for enhanced identification of lead compounds ZIA BC 011468 $282,657 $141,329 Gustafson, Kirk CCR (NCI)
15
Addressing Psychosocial Disparities in Rural Hispanic Cancer Survivors 5K01CA154938-03 $139,976 $34,994 CEBALLOS, RACHEL FRED HUTCHINSON CAN RES CTR
16
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells 5R01CA138738-05 $358,720 $179,360 Brentjens, Renier SLOAN-KETTERING INST CAN RES
17
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research 1U24CA180921-01 $686,990 $137,398 CROWLEY, REBECCA UNIVERSITY OF PITTSBURGH
18
Advancing Clinical Trails in Coastal North Carolina 1U10CA176852-01 $532,663 $37,286 MAGUIRE, PATRICK NEW HANOVER REGIONAL MEDICAL CENTER
19
An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9) 5R21CA170195-02 $185,232 $185,232 Dupuy, Adam UNIVERSITY OF IOWA
20
An integrated systems biology approach for ovarian cancer biomarker discovery 4U01CA152755-04 $248,982 $248,982 DIAMANDIS, ELEFTHERIOS MT SINAI HOSP-SAMUEL LUNENFELD RES INST
21
Analysis of BRCA1 recombination functions 5R01CA095175-10 $277,509 $138,755 SCULLY, RALPH BETH ISRAEL DEACONESS MEDICAL CENTER
22
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca 1R01CA172667-01 $346,404 $346,404 Nomura, Daniel UNIVERSITY OF CALIFORNIA BERKELEY
23
Antibody directed delivery of short interfering RNA for the treatment of ovarian 5K08CA163603-02 $170,631 $170,631 PALANCA-WESSELS, MARIA FRED HUTCHINSON CAN RES CTR
24
Antibody Therapy of Cancer ZIA BC 010891 $650,270 $65,027 Ho, Mitchell CCR (NCI)
25
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis 5R01CA092160-12 $284,228 $93,795 TIGYI, GABOR UNIVERSITY OF TENNESSEE HEALTH SCI CTR
26
Applied Molecular Pathology Laboratory ZIC BC 011257 $157,514 $15,751 Hewitt, Stephen CCR (NCI)
27
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-35S1 $75,000 $3,750 Alberts, David UNIVERSITY OF ARIZONA
28
Arizona Cancer Center-Cancer Center Support Grant 5P30CA023074-35 $3,676,771 $183,839 CRESS, ANNE UNIVERSITY OF ARIZONA
29
Array Microscope Assay for Cancer Cell Mechanics 5R33CA155618-03 $307,678 $153,839 SUPERFINE, RICHARD UNIV OF NORTH CAROLINA CHAPEL HILL
30
Atlantic Breast and Gynecologic Clinical Validation Center 5U01CA084955-14 $468,371 $117,093 Marks, Jeffrey DUKE UNIVERSITY
31
B7-H1 Signaling in Ovarian Cancer 5R01CA164122-02 $291,600 $174,960 Curiel, Tyler UNIV OF TX HSC, SA
32
Bacterial Minicells for Cancer Therapeutics 1F32CA165657-01A1 $52,190 $17,745 Danino, Tal MASSACHUSETTS INSTITUTE OF TECHNOLOGY
33
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research ZIG BC 010856 $14,465,171 $723,259 Custer, Mary CCR (NCI)
34
Baylor College of Medicine Cancer Center 3P30CA125123-07S1 $75,000 $1,500 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
35
Baylor College of Medicine Cancer Center 3P30CA125123-07S2 $43,265 $865 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
36
Baylor College of Medicine Cancer Center 5P30CA125123-07 $3,092,811 $61,856 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
37
BCDDF: Breast cancer detection demonstration project followup study - I ZIA CP010182-01030 $51,681 $10,336 Schairer, Catherine DCEG (NCI)
38
Beaumont Community Clinical Oncology Program 3U10CA095860-12S1 $125,000 $5,000 Robertson, John WILLIAM BEAUMONT HOSPITAL RESEARCH INST
39
Beaumont Community Clinical Oncology Program 5U10CA095860-12 $692,608 $27,704 Robertson, John WILLIAM BEAUMONT HOSPITAL RESEARCH INST
40
Biobehavioral Influences and the Ovarian Tumor Microenvironment 3R01CA140933-05S1 $44,314 $44,314 LUTGENDORF, SUSAN UNIVERSITY OF IOWA
41
Biobehavioral Influences and the Ovarian Tumor Microenvironment 5R01CA140933-05 $447,202 $447,202 LUTGENDORF, SUSAN UNIVERSITY OF IOWA
42
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins ZIA BC 010030 $708,251 $70,825 Ambudkar, Suresh CCR (NCI)
43
Biomedical Applications of Expanded Porphyrins 5R01CA068682-22 $301,027 $301,027 SESSLER, JONATHAN UNIVERSITY OF TEXAS, AUSTIN
44
Bmi-1, a potential therapeutic target in ovarian cancer 7R01CA157481-02 $304,071 $304,071 Bhattacharya, Resham UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
45
BRCA1 Function in Post-Damage Nuclear Foci 5R01CA136512-05 $480,837 $120,209 LIVINGSTON, DAVID DANA-FARBER CANCER INST
46
Breast and Other Cancers in the California Teachers Cohort 5R01CA077398-15 $2,365,386 $236,539 BERNSTEIN, LESLIE CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
47
Breast and Ovary Cancer Clinical Validation Center 5U01CA152637-04 $881,335 $440,668 Li, Christopher FRED HUTCHINSON CAN RES CTR
48
Breast imaging studies in women at high genetic risk of breast cancer ZIA CP010145-07040 $454,638 $68,196 Loud, Jennifer DCEG (NCI)
49
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women 5R01CA129142-05 $503,480 $251,740 KINNEY, ANITA UNIVERSITY OF UTAH
50
Building on the success of the adoptive immunotherapy of cancer ZIA BC 010763 $845,663 $84,566 Restifo, Nicholas CCR (NCI)
Total relevant funding to Ovarian Cancer for this search: $100,558,561
Showing 1 - 50 of 536 results
Go to top